Almoosa Health Company (TADAWUL:4018)
Saudi Arabia
· Delayed Price · Currency is SAR 135.30
-0.10 (-0.07%)
Apr 29, 2026, 3:14 PM AST
Almoosa Health Company Cash Flow Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Net Income | 236.54 | 49.35 | 98.15 | 51.02 | 62.42 | Upgrade
|
| Depreciation & Amortization | 94.6 | 81.73 | 64.76 | 56.94 | 28.49 | Upgrade
|
| Other Amortization | 2.29 | 2.62 | 3.53 | 2.65 | 1.46 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.22 | -0.11 | -0.33 | -0.03 | 0.07 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 0.01 | 0.01 | Upgrade
|
| Loss (Gain) From Sale of Investments | 6.36 | - | - | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | -0.54 | -1.19 | - | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 6.84 | 4.41 | 3.93 | -0.17 | 1.22 | Upgrade
|
| Other Operating Activities | -17.16 | 70.45 | 10.36 | 14.93 | 12.08 | Upgrade
|
| Change in Accounts Receivable | -138.17 | -42.3 | -166.81 | -66.22 | -10.71 | Upgrade
|
| Change in Inventory | -9.95 | -8.81 | -9.29 | -0.16 | -7.77 | Upgrade
|
| Change in Accounts Payable | -17.36 | -1.1 | 3.15 | -49.76 | 75.25 | Upgrade
|
| Change in Other Net Operating Assets | 17.58 | -15.38 | 32.62 | -20.19 | 35.21 | Upgrade
|
| Operating Cash Flow | 180.83 | 139.67 | 40.07 | -10.97 | 197.72 | Upgrade
|
| Operating Cash Flow Growth | 29.47% | 248.56% | - | - | 31.88% | Upgrade
|
| Capital Expenditures | -465.1 | -196.32 | -383.19 | -307.18 | -318.47 | Upgrade
|
| Sale of Property, Plant & Equipment | 2.65 | 1.36 | 23.07 | 0.03 | 0.02 | Upgrade
|
| Sale (Purchase) of Intangibles | -3.14 | -6.33 | -2.16 | -2.89 | -0.31 | Upgrade
|
| Sale (Purchase) of Real Estate | -62.79 | -16.93 | -92.1 | - | - | Upgrade
|
| Investment in Securities | -88.65 | - | - | - | 3.28 | Upgrade
|
| Investing Cash Flow | -617.03 | -218.22 | -454.39 | -310.04 | -315.49 | Upgrade
|
| Long-Term Debt Issued | 127 | 305.59 | 622.91 | 285.67 | 148.91 | Upgrade
|
| Long-Term Debt Repaid | -745.51 | -190.67 | -208 | -7.54 | -7.54 | Upgrade
|
| Total Debt Repaid | -745.51 | -190.67 | -208 | -7.54 | -7.54 | Upgrade
|
| Net Debt Issued (Repaid) | -618.51 | 114.92 | 414.92 | 278.13 | 141.38 | Upgrade
|
| Issuance of Common Stock | 1,182 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -86.39 | -14.01 | - | - | -15.66 | Upgrade
|
| Other Financing Activities | -40.38 | - | - | - | - | Upgrade
|
| Financing Cash Flow | 436.27 | 100.92 | 414.92 | 278.13 | 125.71 | Upgrade
|
| Net Cash Flow | 0.07 | 22.36 | 0.6 | -42.88 | 7.94 | Upgrade
|
| Free Cash Flow | -284.27 | -56.66 | -343.12 | -318.15 | -120.76 | Upgrade
|
| Free Cash Flow Margin | -20.07% | -4.71% | -35.05% | -38.99% | -17.21% | Upgrade
|
| Free Cash Flow Per Share | -6.44 | -1.62 | -9.80 | -9.09 | -1207.55 | Upgrade
|
| Cash Interest Paid | 20.48 | 78.55 | 24.02 | 10 | 1.14 | Upgrade
|
| Levered Free Cash Flow | -354.84 | -68.71 | -369.73 | -359.89 | -122.63 | Upgrade
|
| Unlevered Free Cash Flow | -344.14 | -19.4 | -357.82 | -351.6 | -121.7 | Upgrade
|
| Change in Working Capital | -147.89 | -67.58 | -140.33 | -136.33 | 91.98 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.